Harini A Chakkera

Summary

Country: USA

Publications

  1. ncbi Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs
    Harini A Chakkera
    Department of Medicine, Division of Nephrology, University of California, San Francisco, California, 94143 0532, USA
    J Am Soc Nephrol 16:269-77. 2005
  2. ncbi Results of a prospective randomized trial of sirolimus conversion in kidney transplant recipients on early corticosteroid withdrawal
    Raymond L Heilman
    Department of Medicine, Mayo Clinic in Arizona, Phoenix, AZ 85054, USA
    Transplantation 92:767-73. 2011
  3. ncbi Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression
    Raymond L Heilman
    Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ 85054, USA
    Clin Transplant 22:309-15. 2008
  4. ncbi Hyperglycemia during the immediate period after kidney transplantation
    Harini A Chakkera
    Division of Nephrology, Mayo Clinic, Scottsdale, Arizona, USA
    Clin J Am Soc Nephrol 4:853-9. 2009

Detail Information

Publications4

  1. ncbi Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs
    Harini A Chakkera
    Department of Medicine, Division of Nephrology, University of California, San Francisco, California, 94143 0532, USA
    J Am Soc Nephrol 16:269-77. 2005
    ..26 to 1.36). In conclusion, racial disparities in kidney transplant outcomes seem to persist even in a universal access-to-care system such as the VA. Reasons for worse outcomes among African Americans require further investigation...
  2. ncbi Results of a prospective randomized trial of sirolimus conversion in kidney transplant recipients on early corticosteroid withdrawal
    Raymond L Heilman
    Department of Medicine, Mayo Clinic in Arizona, Phoenix, AZ 85054, USA
    Transplantation 92:767-73. 2011
    ..The use of calcineurin inhibitors is associated with chronic nephrotoxicity and lower glomerular filtration rate (GFR). As a result, one strategy of transplant immunosuppression is calcineurin inhibitor elimination...
  3. ncbi Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression
    Raymond L Heilman
    Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ 85054, USA
    Clin Transplant 22:309-15. 2008
    ..Recent studies have documented good patient and graft outcomes and a low risk of acute rejection with steroid-avoidance immunosuppression in kidney-transplant recipients, but the risk of progressive graft fibrosis is not well studied...
  4. ncbi Hyperglycemia during the immediate period after kidney transplantation
    Harini A Chakkera
    Division of Nephrology, Mayo Clinic, Scottsdale, Arizona, USA
    Clin J Am Soc Nephrol 4:853-9. 2009
    ..To our knowledge, hyperglycemia in the immediate posttransplantation period has not been studied...